Eagle Global Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Eagle Global Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-27,180	Closed	-$127K	–	416
2016 Q3	$127K	Hold	27,180	–	–	﹤0.01%	334
2016 Q2	$179K	Hold	27,180	–	–	0.01%	329
2016 Q1	$173K	Buy	+27,180	New	+$139K	0.01%	331
2015 Q2	–	Sell	-70,870	Closed	-$430K	–	404
2015 Q1	$430K	Buy	+70,870	New	+$472K	0.01%	213

Other funds holding SPPI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Global Advisors's SPPI Position: Q4 2016 in Review

Eagle Global Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2016, closing a stake of 27,180 shares — an estimated $127K sold.

Eagle Global Advisors first reported a position in SPPI in Q1 2015 and held it in 4 quarters. The position peaked at $430K in Q1 2015. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

Eagle Global Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Eagle Global Advisors sold 27,180 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $127K.
Eagle Global Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 4 quarters.
Eagle Global Advisors's Spectrum Pharmaceuticals Inc position peaked at $430K in Q1 2015.
139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on Eagle Global Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.